Gene · 6659
Papers4,583
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,583
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer. | Front Immunol | 2025 | 40735324 | PubTator, text mining | PubMed |
| The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients. | Sci Rep | 2025 | 40730640 | PubTator, text mining | PubMed |
| Sex-determining region Y-Box 4 promotes the progression of advanced hepatocellular carcinoma and enhances regulatory T-cell infiltration and immune suppression. | Cytojournal | 2025 | 40708832 | PubTator, text mining | PubMed |
| miR-340-5p alleviates the damage effect of LPS on nucleus pulposus cells by negatively regulating the expression of SOX4. | J Orthop Surg Res | 2025 | 40691809 | PubTator, text mining | PubMed |
| From preneoplastic lesion to heterogenous tumor: recent insights into hepatoblastoma biology and therapeutic opportunities. | Mol Cancer | 2025 | 40684183 | PubTator, text mining | PubMed |
| VEGFA and APOE regulate distinct functional states of mast cells in hepatocellular carcinoma: A single-cell transcriptome analysis. | Int J Biol Macromol | 2025 | 40683486 | PubTator, text mining | PubMed |
| miRNA-338-3p influences the liver cancer stem cells and lenvatinib resistance properties by targeting SOX4. | Sci Rep | 2025 | 40681569 | PubTator, text mining | PubMed |
| Targeting IGF1R Overcomes Armored and Cold Tumor Microenvironment and Boosts Immune Checkpoint Blockade in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2025 | 40679093 | PubTator, text mining | PubMed |
| Exploring novel genomic biomarkers for response and survival after neoadjuvant chemotherapy and radical cystectomy of muscle-invasive bladder cancer. | ESMO Open | 2025 | 40664147 | PubTator, text mining | PubMed |
| SOX4 promotes triple-negative breast cancer progression by promoting SRPX2 transcription to regulate AKR1C1. | J Mol Histol | 2025 | 40663167 | PubTator, text mining | PubMed |
| Identifying Molecular Modulators of the Vascular Invasion in Rectal Carcinoma: Role of ADAMTS8 and Its Co-Dependent Genes. | Int J Mol Sci | 2025 | 40650042 | PubTator, text mining | PubMed |
| Expression of transcription factors in polycystic ovary syndrome. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40628512 | PubTator, text mining | PubMed |
| SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor. | Blood Res | 2025 | 40613823 | PubTator, text mining | PubMed |
| TNF-α modulates cell proliferation via SOX4/TGF-β/Smad signaling in benign prostatic hyperplasia. | Cell Death Dis | 2025 | 40595502 | PubTator, text mining | PubMed |
| Dissecting the Dual Drug Candidates Against Glioblastoma and Oligodendroglioma Through Integrated Transcriptome Analysis and Virtual Screening. | Cell Biochem Biophys | 2025 | 40571900 | PubTator, text mining | PubMed |
| Integrating single-cell analysis and machine learning to identify COPD hub genes and explore the intervention mechanism of effective component compatibility of Bufei Yishen formula III. | J Ethnopharmacol | 2025 | 40505755 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals the multi-step process of cellular senescence. | Biochem Biophys Rep | 2025 | 40476058 | PubTator, text mining | PubMed |
| Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Patients with Bladder Cancer: A Systematic Review and Meta-analysis. | Ann Surg Oncol | 2025 | 40473997 | PubTator, text mining | PubMed |
| Correction: hsa_circ_0000218/hsa-miR-139-3p/SOX4 regulatory feedback circuit influences the proliferation and apoptosis of gastric cancer cells. | Cytotechnology | 2025 | 40443530 | PubTator, text mining | PubMed |
| Identification and Functional Characterization of a Novel SOX4 Mutation Predisposing to Coffin-Siris Syndromic Congenital Heart Disease. | Children (Basel) | 2025 | 40426787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6659/papers?page=9